Hospital News and Research

RSS

Monoclonal antibody bamlanivimab reduces hospitalization and death in moderate-to-severe COVID-19

Researchers at the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center found that monoclonal antibodies, a COVID-19 treatment administered early after infection, reduce the risk of hospitalization and death by 60 percent in people at high risk of suffering complications from the condition.

20 May 2021

Potentially inappropriate prescribing linked to functional decline in older adults

Individuals are often prescribed increasing numbers of medications as they age, and while many of these prescriptions are justifiable, some may be inappropriate.

19 May 2021

Children with sleep disordered breathing disorder are likely to show aggressive, hyperactive behaviors

While a pint-sized snorer may seem adorable tucked up in bed, studies shows that children with sleep disordered breathing are likely to show aggressive and hyperactive behaviours during the day.

19 May 2021

A study reports the first case of an upper extremity deep vein thrombosis (DVT) recurrence due to COVID-19 infection

Researchers have reported the first case of COVID-19 triggering a rare occurrence of potentially severe blood clots forming in the arms.

19 May 2021

Toll-like receptor 2 (TLR2) detects the SARS-CoV-2 envelope protein and generates inflammatory cytokines

Researchers at St Jude Children’s Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.

19 May 2021

Presence of Anti-SARS-CoV-2 antibodies after 13 months of infection

A new study has been published on the medRxiv* preprint server which focuses on validating the serological assays using a large cohort of healthcare workers.

19 May 2021

Study validates predictive model for identifying pediatric patients at risk for developing blood clots

Monroe Carell Jr. Children's Hospital at Vanderbilt has launched a study to determine the impact of a predictive model for identifying pediatric patients at risk for developing blood clots or venous thromboembolisms (VTEs).

19 May 2021

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

A rigorous meta-analysis of randomized clinical trials (RCTs) that compared the effects of medical therapies alone with medical therapies plus revascularization in patients with stable ischemic heart disease (SIHD) was presented at EuroPCR on May 18, 2021.

19 May 2021

New “Consensus Document” can help manage wound care

DURING the COVID-19 pandemic, pharmacists have increasingly played a key role as being the first point of contact for people with wounds, both chronic and acute.

19 May 2021

New approach could allow cardiologists to predict future heart attacks in high-risk patients

Analysing the forces at work behind the obstructions that cause heart attacks is crucial for identifying patients at risk of these events, says a study published today in eLife.

19 May 2021

Researchers propose new way to treat chronic lung condition

Traditionally, an infection is thought to happen when microbes - bacteria, fungi, or viruses - enter and multiply in the body, and its severity is associated with how prevalent the microbes are in the body.

19 May 2021

Study reveals four coagulation measures associated with migraine susceptibility

Nearly 15 percent of the U.S. population experiences migraine. One subtype of migraine that is not well understood is migraine with aura (MA).

19 May 2021

Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency

A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.

18 May 2021

New coronavirus variants can be effectively eliminated by disinfection, thorough hand washing

The researchers found that the variants have a similar surface stability as the wild type virus under laboratory conditions, but can be effectively eliminated by disinfection and thorough hand washing, heat or alcohol treatment.

18 May 2021

Researchers identify specific influenza targets that could lead to universal flu vaccine for indigenous populations

Researchers have identified specific influenza targets that could be used to better protect Indigenous people from experiencing severe influenza disease through a universal, T cell-based vaccine.

18 May 2021

New COVID-19 testing technology is a cheaper, faster alternative to tube-based RT-PCR tests

Throughout the COVID-19 pandemic, supply chain shortages of reagents and test kits have limited the rapid expansion of clinical testing needed to contain the virus.

18 May 2021

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

In the early months of the COVID-19 pandemic, the United States experienced higher rates of heart disease and cerebrovascular disease deaths, relative to the corresponding months the previous year.

18 May 2021

Doctors now must provide patients their health data, online and on demand

Last summer, Anna Ramsey suffered a flare-up of juvenile dermatomyositis, a rare autoimmune condition, posing a terrifying prospect for the Los Angeles resident: She might have to undergo chemotherapy, further compromising her immune system during a pandemic.

18 May 2021

SpaceX study profiles evolution of antibody response during COVID-19 infection

New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.

18 May 2021

ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity

A team of scientists from the USA and Belgium has recently revealed that the ErbB family of receptor tyrosine kinases play a vital role in regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lifecycle in host cells and that inhibition of these receptors can protect against SARS-CoV-2-induced acute and chronic lung injuries and inflammation.

18 May 2021

Hospital News and Research

Monoclonal antibody bamlanivimab reduces hospitalization and death in moderate-to-severe COVID-19

Potentially inappropriate prescribing linked to functional decline in older adults

Children with sleep disordered breathing disorder are likely to show aggressive, hyperactive behaviors

A study reports the first case of an upper extremity deep vein thrombosis (DVT) recurrence due to COVID-19 infection

Toll-like receptor 2 (TLR2) detects the SARS-CoV-2 envelope protein and generates inflammatory cytokines

Presence of Anti-SARS-CoV-2 antibodies after 13 months of infection

Study validates predictive model for identifying pediatric patients at risk for developing blood clots

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

New “Consensus Document” can help manage wound care

New approach could allow cardiologists to predict future heart attacks in high-risk patients

Researchers propose new way to treat chronic lung condition

Study reveals four coagulation measures associated with migraine susceptibility

Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency

New coronavirus variants can be effectively eliminated by disinfection, thorough hand washing

Researchers identify specific influenza targets that could lead to universal flu vaccine for indigenous populations

New COVID-19 testing technology is a cheaper, faster alternative to tube-based RT-PCR tests

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

Doctors now must provide patients their health data, online and on demand

SpaceX study profiles evolution of antibody response during COVID-19 infection

ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News